192 related articles for article (PubMed ID: 30592078)
1. Rapid assessment of hyperdiploidy in plasma cell disorders using a novel multi-parametric flow cytometry method.
Sidana S; Jevremovic D; Ketterling RP; Tandon N; Dispenzieri A; Gertz MA; Greipp PT; Baughn LB; Buadi FK; Lacy MQ; Morice W; Hanson C; Timm M; Dingli D; Hayman SR; Gonsalves WI; Kapoor P; Kyle RA; Leung N; Go RS; Lust JA; Rajkumar SV; Kumar SK
Am J Hematol; 2019 Apr; 94(4):424-430. PubMed ID: 30592078
[TBL] [Abstract][Full Text] [Related]
2. Hyperdiploidy is a common finding in monoclonal gammopathy of undetermined significance and monosomy 13 is restricted to these hyperdiploid patients.
Brousseau M; Leleu X; Gerard J; Gastinne T; Godon A; Genevieve F; Dib M; Lai JL; Facon T; Zandecki M;
Clin Cancer Res; 2007 Oct; 13(20):6026-31. PubMed ID: 17947464
[TBL] [Abstract][Full Text] [Related]
3. A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Chng WJ; Van Wier SA; Ahmann GJ; Winkler JM; Jalal SM; Bergsagel PL; Chesi M; Trendle MC; Oken MM; Blood E; Henderson K; Santana-Dávila R; Kyle RA; Gertz MA; Lacy MQ; Dispenzieri A; Greipp PR; Fonseca R
Blood; 2005 Sep; 106(6):2156-61. PubMed ID: 15920009
[TBL] [Abstract][Full Text] [Related]
4. Ploidy, as detected by fluorescence in situ hybridization, defines different subgroups in multiple myeloma.
Wuilleme S; Robillard N; Lodé L; Magrangeas F; Beris H; Harousseau JL; Proffitt J; Minvielle S; Avet-Loiseau H;
Leukemia; 2005 Feb; 19(2):275-8. PubMed ID: 15538401
[TBL] [Abstract][Full Text] [Related]
5. Understanding the role of hyperdiploidy in myeloma prognosis: which trisomies really matter?
Chretien ML; Corre J; Lauwers-Cances V; Magrangeas F; Cleynen A; Yon E; Hulin C; Leleu X; Orsini-Piocelle F; Blade JS; Sohn C; Karlin L; Delbrel X; Hebraud B; Roussel M; Marit G; Garderet L; Mohty M; Rodon P; Voillat L; Royer B; Jaccard A; Belhadj K; Fontan J; Caillot D; Stoppa AM; Attal M; Facon T; Moreau P; Minvielle S; Avet-Loiseau H
Blood; 2015 Dec; 126(25):2713-9. PubMed ID: 26516228
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of hyperdiploidy in multiple myeloma patients with high-risk cytogenetics: a pilot study in China.
Mei J; Zhai Y; Li H; Li F; Zhou X; Song P; Zhao Q; Yu Y; An Z; Wang L
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2263-2273. PubMed ID: 30167888
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological Characteristics of Hyperdiploidy with High-Risk Cytogenetics in Multiple Myeloma.
Yang N; Mun YC; Seong CM; Huh HJ; Huh J
Ann Lab Med; 2018 Mar; 38(2):160-164. PubMed ID: 29214761
[TBL] [Abstract][Full Text] [Related]
8. Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.
Kumar S; Fonseca R; Ketterling RP; Dispenzieri A; Lacy MQ; Gertz MA; Hayman SR; Buadi FK; Dingli D; Knudson RA; Greenberg A; Russell SJ; Zeldenrust SR; Lust JA; Kyle RA; Bergsagel L; Rajkumar SV
Blood; 2012 Mar; 119(9):2100-5. PubMed ID: 22234687
[TBL] [Abstract][Full Text] [Related]
9. Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.
Tabernero D; San Miguel JF; Garcia-Sanz M; Nájera L; García-Isidoro M; Peréz-Simon JA; Gonzalez M; Wiegant J; Raap AK; Orfão A
Am J Pathol; 1996 Jul; 149(1):153-61. PubMed ID: 8686739
[TBL] [Abstract][Full Text] [Related]
10. Detection of hyperdiploid karyotypes (>50 chromosomes) in childhood acute lymphoblastic leukemia (ALL) using fluorescence in situ hybridization (FISH).
Ritterbach J; Hiddemann W; Beck JD; Schrappe M; Janka-Schaub G; Ludwig WD; Harbott J; Lampert F
Leukemia; 1998 Mar; 12(3):427-33. PubMed ID: 9529139
[TBL] [Abstract][Full Text] [Related]
11. Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities.
Lim JH; Seo EJ; Park CJ; Jang S; Chi HS; Suh C; Kim H; Kim SR
Eur J Haematol; 2014 Apr; 92(4):313-20. PubMed ID: 24372944
[TBL] [Abstract][Full Text] [Related]
12. Hypodiploidy is a major prognostic factor in multiple myeloma.
Smadja NV; Bastard C; Brigaudeau C; Leroux D; Fruchart C;
Blood; 2001 Oct; 98(7):2229-38. PubMed ID: 11568011
[TBL] [Abstract][Full Text] [Related]
13. Role of Conventional Karyotyping in Multiple Myeloma in the Era of Modern Treatment and FISH Analysis.
Soekojo CY; Wang GM; Chen Y; Casan J; Wolyncewicz G; Lin A; Poon LM; de Mel S; Koh LP; Tan LK; Ooi MG; Nagarajan C; Liu Y; Lai YY; Huang XJ; Spencer A; Gopalakrishnan SK; Lu J; Chng WJ
Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e470-e477. PubMed ID: 31171473
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
Heerema NA; Sather HN; Sensel MG; Zhang T; Hutchinson RJ; Nachman JB; Lange BJ; Steinherz PG; Bostrom BC; Reaman GH; Gaynon PS; Uckun FM
J Clin Oncol; 2000 May; 18(9):1876-87. PubMed ID: 10784628
[TBL] [Abstract][Full Text] [Related]
15. Hyperdiploidy as a rare event that accompanies poor prognosis markers in CLL.
González-Gascón Y Marín I; Martín AÁ; Hernández-Sanchez M; Robledo C; Hermosín ML; de Las Heras N; Lacalle L; Galende J; de Arriba F; Rodríguez-Vicente AE; Hernández JÁ; Hernández-Rivas JM
Eur J Haematol; 2017 Feb; 98(2):142-148. PubMed ID: 27717146
[TBL] [Abstract][Full Text] [Related]
16. Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis.
Li H; Li F; Zhou X; Mei J; Song P; An Z; Zhao Q; Guo X; Wang X; Zhai Y
Ann Hematol; 2019 May; 98(5):1185-1195. PubMed ID: 30721336
[TBL] [Abstract][Full Text] [Related]
17. A novel and easy FxCycle™ violet based flow cytometric method for simultaneous assessment of DNA ploidy and six-color immunophenotyping.
Tembhare P; Badrinath Y; Ghogale S; Patkar N; Dhole N; Dalavi P; Kunder N; Kumar A; Gujral S; Subramanian PG
Cytometry A; 2016 Mar; 89(3):281-91. PubMed ID: 26671309
[TBL] [Abstract][Full Text] [Related]
18. Classify hyperdiploidy status of multiple myeloma patients using gene expression profiles.
Li Y; Wang X; Zheng H; Wang C; Minvielle S; Magrangeas F; Avet-Loiseau H; Shah PK; Zhang Y; Munshi NC; Li C
PLoS One; 2013; 8(3):e58809. PubMed ID: 23554930
[TBL] [Abstract][Full Text] [Related]
19. Metaphase cytogenetics and plasma cell proliferation index for risk stratification in newly diagnosed multiple myeloma.
Mellors PW; Binder M; Ketterling RP; Greipp PT; Baughn LB; Peterson JF; Jevremovic D; Pearce KE; Buadi FK; Lacy MQ; Gertz MA; Dispenzieri A; Hayman SR; Kapoor P; Gonsalves WI; Hwa YL; Fonder A; Hobbs M; Kourelis T; Warsame R; Lust JA; Leung N; Go RS; Kyle RA; Rajkumar SV; Kumar SK
Blood Adv; 2020 May; 4(10):2236-2244. PubMed ID: 32442300
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic significance of chromosome abnormalities in childhood acute lymphoblastic leukemia.
Oláh E; Balogh E; Kajtár P; Pajor L; Jakab Z; Kiss C
Ann N Y Acad Sci; 1997 Sep; 824():8-27. PubMed ID: 9382457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
